EFFECT OF ADDING INTRATHECAL DEXMEDETOMIDINE AS AN ADJUVANT TO HYPERBARIC BUPIVACAINE FOR ELECTIVE CAESAREAN SECTION
SUSHRUTH M R, DINESH GOVINDA RAO.
Abstract
Context: Caesarean section performed under subarachnoid block is often accompanied by visceral pain. Hence, various adjuvants have been tried to address this problem and to provide prolonged post-operative analgesia. Highly selective α2-agonist dexmedetomidine is increasingly used as an intrathecal adjuvant.
Aims: The study was designed to evaluate dexmedetomidine 5µg as adjuvant to intrathecal hyperbaric 0.5% bupivacaine 9mg in caesarean sections with respect to block characteristics, sedation and neonatal APGAR scores.
Settings and Design: A prospective, randomised, double blinded, controlled study
Methods and Material: 60 parturients undergoing elective lower segment caesarean section were assigned to 2 groups (n=30) to receive either 0.5% hyperbaric bupivacaine 9 mg with dexmedetomidine 5 µg (Group D) or 0.5% hyperbaric bupivacaine 9 mg with saline (Group C).
Statistical analysis used: Data obtained were compiled and analysed with appropriate tests. A p-value of
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
